S F Williams

854 total citations
16 papers, 424 citations indexed

About

S F Williams is a scholar working on Hematology, Oncology and Cancer Research. According to data from OpenAlex, S F Williams has authored 16 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in S F Williams's work include Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). S F Williams is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). S F Williams collaborates with scholars based in United States and Israel. S F Williams's co-authors include Jacob D. Bitran, Rosemarie Mick, Theresa Gilewski, Richard K. Desser, Arno J. Mundt, Dennis E. Hallahan, Elizabeth Barker, H M Golomb, Richard A. Larson and Todd M. Zimmerman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S F Williams

16 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S F Williams United States	11	261	185	97	67	55	16	424
Neal P. Christiansen United States	14	158 0.6×	158 0.9×	37 0.4×	62 0.9×	47 0.9×	32	474
Metter Ge United States	9	261 1.0×	189 1.0×	22 0.2×	127 1.9×	59 1.1×	13	538
Luigi Salvagno Italy	15	270 1.0×	121 0.7×	35 0.4×	254 3.8×	72 1.3×	46	618
C Jacquillat France	10	168 0.6×	149 0.8×	32 0.3×	73 1.1×	76 1.4×	62	444
Samuel Kopel United States	8	197 0.8×	369 2.0×	45 0.5×	81 1.2×	101 1.8×	14	628
I D H Todd United Kingdom	7	133 0.5×	68 0.4×	39 0.4×	75 1.1×	53 1.0×	10	311
Isabelle Genvresse Germany	12	157 0.6×	169 0.9×	23 0.2×	104 1.6×	99 1.8×	27	472
Macdonald Js United States	10	248 1.0×	86 0.5×	63 0.6×	67 1.0×	26 0.5×	20	436
Kristín Bjarnadóttir Iceland	5	166 0.6×	54 0.3×	82 0.8×	61 0.9×	35 0.6×	8	335
M.R. Sertoli Italy	15	432 1.7×	45 0.2×	106 1.1×	105 1.6×	20 0.4×	34	630

Countries citing papers authored by S F Williams

Since Specialization

Citations

This map shows the geographic impact of S F Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S F Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S F Williams more than expected).

Fields of papers citing papers by S F Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S F Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S F Williams. The network helps show where S F Williams may publish in the future.

Co-authorship network of co-authors of S F Williams

This figure shows the co-authorship network connecting the top 25 collaborators of S F Williams. A scholar is included among the top collaborators of S F Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S F Williams. S F Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gordon, Leo I., Martin S. Tallman, Jane N. Winter, et al.. (2006). Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 37(6). 553–557. 16 indexed citations

Valone, Frank H., et al.. (2000). Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer. Cytotherapy. 2(3). 179–185. 1 indexed citations

Zimmerman, Todd M., et al.. (1999). The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis product. Cytotherapy. 1(2). 141–146. 16 indexed citations

Zimmerman, Todd M. & S F Williams. (1998). Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors.. PubMed. 4(4). 257–64. 5 indexed citations

Zimmerman, Todd M., et al.. (1998). A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma. Cancer. 83(8). 1540–1545. 6 indexed citations

Smith, Stephen L., Julia Glade Bender, Christoph Berger, et al.. (1997). Neutrophil Maturation of CD34+ Cells from Peripheral Blood and Bone Marrow in Serum-Free Culture Medium with PIXY321 and Granulocyte-Colony Stimulating Factor (G-CSF). Journal of Hematotherapy. 6(4). 323–334. 10 indexed citations

Mundt, Arno J., S F Williams, & Dennis E. Hallahan. (1997). High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 39(3). 617–625. 30 indexed citations

Meyers, S. N., et al.. (1994). Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.. PubMed. 389. 421–7. 2 indexed citations

Bender, Julia Glade, et al.. (1992). Characterization of cd34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy. Stem Cells. 10(S1). 23–25. 10 indexed citations

10.

Geller, Robert B., S Myers, S M Devine, et al.. (1992). Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.. PubMed. 9(1). 41–7. 14 indexed citations

11.

Williams, S F, Theresa Gilewski, Rosemarie Mick, & Jacob D. Bitran. (1992). High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.. Journal of Clinical Oncology. 10(11). 1743–1747. 109 indexed citations

12.

Ilan, Yaron, et al.. (1991). Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature. Leukemia & lymphoma. 5(4). 249–254. 1 indexed citations

13.

Williams, S F, et al.. (1990). Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.. PubMed. 5(2). 129–33. 74 indexed citations

14.

Williams, S F, et al.. (1989). High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.. Journal of Clinical Oncology. 7(12). 1824–1830. 88 indexed citations

15.

Williams, S F & Richard A. Larson. (1989). HYPERSENSITIVITY REACTION TO HIGH‐DOSE CYTARABINE. British Journal of Haematology. 73(2). 274–275. 13 indexed citations

16.

Schilsky, Richard L., et al.. (1987). Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 5(3). 419–425. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact